News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Features COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention Michael O'Riordan April 24, 2020
News Features Obesity and COVID-19: Theories and Blame Fill the Scientific Void Shelley Wood April 21, 2020
News Features ESC Heart Failure 2019 At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback Shelley Wood May 30, 2019
News Features Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option? Shelley Wood April 30, 2019
News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017
News Features Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana Ashley Lyles July 13, 2017
News Features How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts Michael O'Riordan May 23, 2017
News Features The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol Michael O'Riordan January 24, 2017
News Features Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways Michael O'Riordan October 05, 2016
News Features Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent Caitlin E. Cox June 17, 2016
News Features Possible Turf War Brewing Over Delivery of Acute Stroke Interventions Todd Neale December 28, 2015
News Features Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3 June 24, 2014